Li Jingmei, Humphreys Keith, Ho Peh Joo, Eriksson Mikael, Darai-Ramqvist Eva, Lindström Linda Sofie, Hall Per, Czene Kamila
Department of Human Genetics, Genome Institute of Singapore, Singapore, Singapore.
Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
JNCI Cancer Spectr. 2018 Dec 10;2(3):pky051. doi: 10.1093/jncics/pky051. eCollection 2018 Jul.
To understand which breast cancer (BC) risk factors also increase the risk of fibroadenoma and investigate whether these factors have the same effect in BC patients with previous fibroadenoma.
Using multistate survival analysis on a large dataset (n58 322), we examined the effects of BC risk factors on transitions between three states: event-free, biopsy-confirmed fibroadenoma, and BC. Hazard ratios and corresponding 95% confidence intervals associated with covariate effects were estimated. Median follow-up time was 25.3 years.
The mean ages at diagnosis of fibroadenoma and BC were 42.6 and 48.3 years, respectively. Participant characteristics known to increase the risk of BC were found to increase the risk of fibroadenoma (family history of BC and higher education). Participant characteristics known to confer protective effects for BC (older age at menarche, more children, and larger childhood body size) were found to reduce fibroadenoma risk. The effect sizes associated with the direct transitions from event-free to fibroadenoma and BC were generally not different for the covariates tested. Age at fibroadenoma diagnosis was associated with the transition from fibroadenoma to BC (hazard ratio = 1.07 [95% confidence interval = 1.03 to 1.12]).
We showed that biopsy-confirmed fibroadenomas shared many risk factors with BC. More work is needed to understand the relationships between fibroadenoma and BC to identify women who are at high risk of developing BC after a fibroadenoma diagnosis.
为了解哪些乳腺癌(BC)风险因素也会增加纤维腺瘤的风险,并研究这些因素在既往有纤维腺瘤的BC患者中是否具有相同的作用。
我们对一个大型数据集(n = 58322)进行多状态生存分析,研究BC风险因素对三种状态之间转变的影响:无事件、活检确诊的纤维腺瘤和BC。估计了与协变量效应相关的风险比及相应的95%置信区间。中位随访时间为25.3年。
纤维腺瘤和BC的诊断平均年龄分别为42.6岁和48.3岁。已知增加BC风险的参与者特征也会增加纤维腺瘤的风险(BC家族史和高等教育)。已知对BC有保护作用的参与者特征(初潮年龄较大、子女较多和儿童期体型较大)可降低纤维腺瘤风险。对于所测试的协变量,从无事件直接转变为纤维腺瘤和BC的效应大小通常没有差异。纤维腺瘤诊断时的年龄与从纤维腺瘤转变为BC相关(风险比 = 1.07 [95%置信区间 = 1.03至1.12])。
我们表明活检确诊的纤维腺瘤与BC有许多共同的风险因素。需要开展更多工作来了解纤维腺瘤与BC之间的关系,以识别在诊断纤维腺瘤后有患BC高风险的女性。